Sign in

CIK 0001799788 · Non-accelerated filer<br>Smaller reporting company

Greenwich LifeSciences, Inc.

Sign in to watch
Ticker
GLSI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
205473709
Phone
203-434-3290
Business address
3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477
  1. 4 Other disposition 10% owner disposed of 561,798 shares (other)
  2. 4 Open-market buy Director bought 1,000 shares at $5.39 ($5,386)
  3. 4 Open-market buy Chief Medical Officer bought 1,000 shares at $5.10 ($5,100)
  4. 4 Open-market buy Director bought 1,500 shares at $5.40 ($8,100)
  5. 4 Open-market buy Director bought 1,000 shares at $5.37 ($5,370)
  6. 4 Open-market buy Director bought 2,000 shares at $5.40 ($10,800)
  7. 4 Open-market buy CEO and CFO bought 2,000 shares at $5.40 ($10,795)
  8. 4 Option exercise 10% owner acquired 129,400 shares (option exercise)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market buy CEO and CFO bought 16,667 shares at $4.60 ($76,710)
  11. 4 Open-market buy Director bought 8,333 shares at $4.60 ($38,353)
  12. 3/A Insider 3/A
  13. 4 Option exercise CEO and CFO acquired 1,665,124 shares (option exercise)
  14. 4 Option exercise Director acquired 116,575 shares (option exercise)
  15. 4 Option exercise Director acquired 171,622 shares (option exercise)
  16. 4 Open-market buy Director bought 74,782 shares at $5.75 ($429,997)
  17. 4 Open-market buy CEO and CFO bought 114,347 shares at $5.75 ($657,495)
  18. 4 Open-market buy Chief Medical Officer bought 1,739 shares at $5.75 ($9,999)
  19. 4 Open-market buy Director bought 2,608 shares at $5.75 ($14,996)
  20. 3 Insider Initial Statement of Ownership

Page 7 of 8 · 146 filings